Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.
Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, Cohen A, Woody G, Jacobs P. Saxon AJ, et al. Among authors: hillhouse m. Drug Alcohol Depend. 2013 Feb 1;128(1-2):71-6. doi: 10.1016/j.drugalcdep.2012.08.002. Epub 2012 Aug 22. Drug Alcohol Depend. 2013. PMID: 22921476 Free PMC article. Clinical Trial.
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J. Ling W, et al. Among authors: hillhouse mp. Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21. Addiction. 2016. PMID: 26948856 Free PMC article. Clinical Trial.
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W. Woody G, et al. Among authors: hillhouse m. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):e142-3. doi: 10.1097/QAI.0000000000000344. J Acquir Immune Defic Syndr. 2014. PMID: 25243431 Free PMC article. No abstract available.
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Potter JS, et al. J Stud Alcohol Drugs. 2013 Jul;74(4):605-13. doi: 10.15288/jsad.2013.74.605. J Stud Alcohol Drugs. 2013. PMID: 23739025 Free PMC article. Clinical Trial.
Buprenorphine tapering schedule and illicit opioid use.
Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R. Ling W, et al. Among authors: hillhouse m. Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x. Addiction. 2009. PMID: 19149822 Free PMC article. Clinical Trial.
Participant characteristics and buprenorphine dose.
Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W. Hillhouse M, et al. Am J Drug Alcohol Abuse. 2011 Sep;37(5):453-9. doi: 10.3109/00952990.2011.596974. Am J Drug Alcohol Abuse. 2011. PMID: 21854290 Free PMC article. Clinical Trial.
61 results